Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma

Immunotherapy for the Treatment of Urothelial Carcinoma

Lung adenocarcinoma may be a more susceptive subtype to a dendritic cell-based cancer vaccine than other subtypes of non-small cell lung cancers: a multicenter retrospective analysis

Targeting breast cancer stem cells by dendritic cell vaccination in humanized mice with breast tumor: preliminary results

PI3K/Akt/mTOR Signaling and Plasma Membrane Proteins Are Implicated in Responsiveness to Adjuvant Dendritic Cell Vaccination for Metastatic Colorectal Cancer

Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine

Immunotherapy in atypical teratoid-rhabdoid tumors: Data from a survey of the HGG-Immuno Group

A Perspective of Immunotherapy for Prostate Cancer

PD-1 blockade enhances the vaccination-induced immune response in glioma

Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ER/HER2 early breast cancer